MRI findings of parotid acinic cell carcinoma in 19 consecutive cases

doi:10.19439/j.sjos.2022.03.020

Abstract

Abstract: PURPOSE: To describe the MRI features of acinar cell carcinoma of parotid gland (AciCC) and to evaluate the diagnostic value of MR functional imaging. METHODS: A total of 269 cases of maxillofacial AciCC confirmed by surgery and pathology were analyzed. Among them, nineteen subjects with AciCC in the parotid gland underwent preoperative MRI examination (non-enhanced scan for one case, enhanced scan for 18 cases), seventeen patients underwent diffusion-weighted imaging scan, and 15 patients underwent dynamic contrast-enhanced scan. MRI findings of 19 patients were retrospectively analyzed. The lesion size, location, morphology, margin, internal composition, enhancement pattern and functional imaging characteristics were analyzed. SPSS 25.0 software package was used for statistical analysis. RESULTS: Among 269 cases of maxillofacial AciCC, there were 108 males and 161 females, male: female = 1:1.49, aged from 4 to 89 years, with a mean age of (45.95±17.33) years. 84.4% (227/269) were located in the parotid gland. On MRI images, 78.9% (15/19) had well-defined margin, 57.9% (11/19) were round or oval, and 36.8% (7/19) were lobed nodules. One case had irregular morphology and peripheral invasion. The range of maximum diameter was 6-56 mm, averaging (24.8±15.3) mm. Internal composition showed 57.9% (11/19) were cystic solid, 42.1% (8/19) were solid, 31.6% (6/19) had bleeding. T2-weighted MRI showed 52.6% (10/19) with envelope structure, 15.8% (3/19) with low signal separation inside, 38.9%(7/18) had uniform enhancement, and 61.1%(11/18) had uneven enhancement. Functional imaging showed the mean ADC value of tumor was (1.026±0.194)×10^-3 mm²/s(n=17). 86.7%(13/15) TIC was type Ⅱ. CONCLUSIONS: Most maxillofacial AciCC are located in the parotid gland. It is difficult to distinguish AciCC from benign tumors with conventional MRI in morphology. The ADC value of AciCC is lower than that of benign tumors, and the type of TIC curve is mostly type Ⅱ. Combination of morphology and functional imaging can improve the diagnostic accuracy of this disease.

Key words: Parotid gland, Acinic cell carcinoma, Magnetic resonance image, Functional imaging

CLC Number:

R739.8

XIAO Hua, TAO Xiao-feng, ZHU Wen-jing, CHEN Qian-qian. MRI findings of parotid acinic cell carcinoma in 19 consecutive cases[J]. Shanghai Journal of Stomatology, 2022, 31(3): 322-326.

References

[1] Spiro RH, Huvos AG, Strong EW.Acinic cell carcinoma of salivary origin. a clinicopathologic study of 67 cases[J]. Cancer,1978, 41(3): 924-935.
[2] EI-Naggar AK, Chan JKC, Grandis JR, et al.WHO classification of head and neck tumours[M]. 4th Ed. IARC: Lyon, 2017: 166-167.
[3] Suh SI, Seol HY, Kim TK, et al.Acinic cell carcinoma of the head and neck: radiologic-pathologic correlation[J]. J Comput Assist Tomogr, 2005, 29(1): 121-126.
[4] Ariji Y, Maeda H, Shimozato K, et al.Imaging features of acinic cell carcinoma: three case reports and a review of the literature[J]. Oral Radiol, 2004, 20(1): 22-31.
[5] Sakai O, Nakashima N, Takata Y, et al.Acinic cell carcinoma of the parotid gland: CT and MRI[J]. Neuroradiology, 1996, 38(7): 675-679.
[6] Buhas CL, Rosca E, Mutiu G, et al.Acinic cell carcinoma of minor salivary glands-case report[J]. Rom J Morphol Embryol, 2017, 58(3): 1003-1007.
[7] Yabuuchi H, Matsuo Y, Kamitani T, et al.Parotid gland tumors: can addition of diffusion-weighted MR imaging to dynamic contrast-enhanced MR imaging improve diagnostic accuracy in characterization?[J]. Radiology, 2008, 249(3): 909-916.
[8] 赵志国, 高丹, 王瑾, 等. 896例腮腺肿瘤临床回顾分析[J]. 上海口腔医学, 2017, 26(6): 605-609.
[9] Buxton RW, Maxwell JH, French AJ.Surgical treatment of epithelial tumors of the parotid gland[J]. Surg Gynecol Obstet, 1953, 97(4): 401-416.
[10] Hoffman HT, Karnell LH, Robinson RA, et al.National Cancer Data Base report on cancer of the head and neck: acinic cell carcinoma[J]. Head Neck, 1999, 21(4): 297-309.
[11] Buiret G, Céruse P, Ramadeet A, et al.Acinic cell carcinoma of the parotid gland with skull base invasion: case study, managed by exclusive external 3D radiation therapy[J]. Eur Ann Otorhinolaryngol Head Neck Dis, 2012, 129(2): 111-114.
[12] Gomez DR, Katabi N, Zhung J, et al.Clinical and pathologic prognostic features in acinic cell carcinoma of the parotid gland[J]. Cancer, 2009, 115(10): 2128-2137.
[13] Wahlberg P, Anderson H, Biorklund A, et al.Carcinoma of the parotid and submandibular glands-a study of survival in 2465 patients[J]. Oral Oncol, 2002, 38(7): 706-713.
[14] Kashiwagi N, Nakatsuka SI, Murakami T, et al.MR imaging features of mammary analogue secretory carcinoma and acinic cell carcinoma of the salivary gland: a preliminary report[J]. Dentomaxillofac Radiol, 2018, 47(5): 20170218.
[15] Kuwabara H, Yamamoto K, Terada T, et al.Hemorrhage of MRI and immunohistochemical panels distinguish secretory carcinoma from acinic cell carcinoma[J]. Laryngoscope Investig Otolaryngol, 2018, 3(4): 268-274.
[16] Karaman CZ, Tanyeri A, Ozgur R, et al.Parotid gland tumors: comparison of conventional and diffusion-weighted MRI findings with histopathological results[J]. Dentomaxillofac Radiol, 2021, 50(4): 20200391.
[17] Yamamoto T, Kimura H, Hayashi K, et al.Pseudo-continuous arterial spin labeling MR images in Warthin tumors and pleomorphic adenomas of the parotid gland: qualitative and quantitative analyses and their correlation with histopathologic and DWI and dynamic contrast enhanced MRI findings[J]. Neuroradiology, 2018, 60(8): 803-812.
[18] Tao X, Yang G, Wang P, et al.The value of combining conventional, diffusion-weighted and dynamic contrast-enhanced MR imaging for the diagnosis of parotid gland tumours[J]. Dentomaxillofac Radiol, 2017, 46(6): 20160434.
[19] Okahara M, Kiyosue H, Hori Y, et al.Parotid tumors: MR imaging with pathological correlation[J]. Eur Radiol, 2003, 13(Suppl 4): L25-33.